Raymond James Financial
PLSE icon

Raymond James Financial’s Pulse Biosciences PLSE Stock Holding History

Raymond James Financial’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.09M Buy
21,819
+6,539
+43% +$276K ﹤0.01% 3977
2026
Q2 		$424K Buy
+15,280
New +$361K ﹤0.01% 4623
2025
Q3 		– Sell
-990
Closed -$14.9K – 6272
2025
Q2 		$14.9K Buy
+990
New +$16.4K ﹤0.01% 5725

Other funds holding PLSE

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $33.4B AUM 56.97% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $116B AUM 33.19% 1-Year Est. Return

Raymond James Financial's PLSE Position: Q3 2026 in Review

Raymond James Financial increased its Pulse Biosciences (PLSE) stake by 43% in Q3 2026, buying an estimated $276K and bringing the position to 21,819 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #3977.

Raymond James Financial first reported a position in PLSE in Q2 2025 and has held it in 3 quarters since. 97 funds tracked by Wall St. Rank hold PLSE as of Q3 2026.

  • Raymond James Financial held 21,819 shares of Pulse Biosciences worth $1.09M as of Q3 2026.
  • Raymond James Financial bought 6,539 Pulse Biosciences shares in Q3 2026, an estimated $276K.
  • Pulse Biosciences made up ﹤0.01% of Raymond James Financial's portfolio in Q3 2026, its #3977 holding.
  • Raymond James Financial first reported a position in Pulse Biosciences in Q2 2025 and has held it in 3 quarters since.
  • 97 funds tracked by Wall St. Rank held Pulse Biosciences as of Q3 2026.

Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.